ALDO NAVARRO OVIEDO: Open Payments
NPI 1235487703 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 17 payments from 12 companies in 2025. Trend: 2023 $171 · 2024 $875 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Agios Pharmaceuticals, Inc. | 1 | $31 |
| Intra-Sana Laboratories | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, AUSTEDO XR, PYRUKYND, RELTONE 200 MG, COLLAGENASE SANTYL, Cologuard Collection Kit, CAPLYTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
